The Discounted Cash Flow (DCF) valuation of Adaptive Biotechnologies Corp (ADPT) is (25.77) USD. With the latest stock price at 11.74 USD, the upside of Adaptive Biotechnologies Corp based on DCF is -319.5%.
Based on the latest price of 11.74 USD and our DCF valuation, Adaptive Biotechnologies Corp (ADPT) is a sell. selling ADPT stocks now will result in a potential gain of 319.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.9% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (50.12) - (17.87) | (25.77) |
| Upside | -526.9% - -252.2% | -319.5% |